Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Shares of Danish weight loss drug company fall, Zealand drops more than 20%

Shares of Danish weight loss drug company fall, Zealand drops more than 20%

华尔街见闻华尔街见闻2026/06/08 14:42
Show original
Novo Nordisk's investigational drug CagriSema achieved its primary endpoints in three Phase 3 clinical trials. Data show that compared to placebo and Semaglutide, the drug led to statistically significant reductions in both glycated hemoglobin (HbA1c) and body weight among adults with type 2 diabetes.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!